Anavex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
AVXL Key Statistics
Stock Snapshot
With a market cap of 350.69M, Anavex(AVXL) trades at $3.93. The stock has a price-to-earnings ratio of -7.39.
During the trading session on 2025-12-17, Anavex(AVXL) shares reached a daily high of $4.09 and a low of $3.81. At a current price of $3.93, the stock is +3.2% higher than the low and still -4.0% under the high.
Trading activity shows a volume of 2.71M, compared to an average daily volume of 2.54M.
Over the past 52 weeks, Anavex(AVXL) stock has traded between a high of $14.44 and a low of $2.86.
Over the past 52 weeks, Anavex(AVXL) stock has traded between a high of $14.44 and a low of $2.86.
AVXL News
Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Anavex Life Sciences and keeping the price target at $20.00. Claim 50% Off TipRanks Premiu...
Anavex (AVXL) provided an update on the regulatory review in the EU for blarcamesine to treat early Alzheimer’s disease. As per previous communication, the Euro...